Skip to main content

CITADEL ADVISORS LLC

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in KYTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$501,626
-$2,087,566 QoQ
Shares Held
58,126
-78.9% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Derivatives in KYTX

reported options exposure · as of Mar 31, 2026
CallValue
$254,585
CallShares
29,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names. KYTX ranks #255 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KYTX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $254,585 29,500
2026-03-31 $501,626 58,126
2025-12-31 $376,000 40,000
2025-12-31 $2,589,192 275,446
2025-12-31 $361,900 38,500
2025-09-30 $406,200 67,700
2025-09-30 $105,996 17,666
2025-06-30 $120,651 39,300
2025-06-30 $998,944 325,389
2025-03-31 $3,088 1,600
2025-03-31 $1,917,686 993,620
2025-03-31 $3,088 1,600
2024-12-31 $101,728 27,200
2024-12-31 $10,472 2,800
2024-12-31 $607,072 162,319
2024-09-30 $6,846 1,400
2024-09-30 $67,482 13,800
2024-09-30 $673,543 137,739
2024-06-30 $102,000 13,600
2024-06-30 $1,711,027 228,137
2024-06-30 $44,250 5,900
2024-03-31 $4,968 200
2024-03-31 $13,009,775 523,743
2024-03-31 $181,332 7,300